Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Quansheng, Feng"'
Autor:
Haihui Liu, Xiaoluo Sun, Sian Tao, Shu Liu, Xin Wang, Qiuping Chen, Wenjun Wu, Chongcheng Xi, Baixue Li, Quansheng Feng, Jibin Liu
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
IntroductionDue to the high mortality rate and increasing severity of antibiotic resistance, there is a growing interest in new treatments for Klebsiella pneumoniae (KP)-induced pneumonia. Research has shown that the single herbs of SiHuangQingXinWan
Externí odkaz:
https://doaj.org/article/b21342527fe8471c8d7af76373a36b5d
Publikováno v:
Heliyon, Vol 10, Iss 16, Pp e36267- (2024)
Chronic hepatitis B infection (CHB) is a major risk factor for the development of hepatocellular carcinoma (HCC) globally and continues to pose a significant global health challenge. Jiawei Yinchenhao decoction (JWYCH) is a modified version of Yinche
Externí odkaz:
https://doaj.org/article/51d21f99441c49c6b98bc8534d5edc26
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Background and aimsMetabolic reprogramming has been found to be a typical feature of tumors. Hepatocellular carcinoma (HCC), a cancer with high morbidity and mortality, has been extensively studied for its metabolic reprogramming-related mechanisms.
Externí odkaz:
https://doaj.org/article/6e9a5d231ffe4bde8a64b8231ee42f9d
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Background: The occurrence and development of Hepatic fibrosis (HF) are closely related to the gut microbial composition and alterations in host metabolism. Qijia Rougan decoction (QJ) is a traditional Chinese medicine compound utilized clinically fo
Externí odkaz:
https://doaj.org/article/29b78f3732c64d819ddde54d82b1f3be
Publikováno v:
PLoS ONE, Vol 19, Iss 3 (2024)
Externí odkaz:
https://doaj.org/article/a57df040f1fd4412b66ff1304e57c6b7
Autor:
Hongfei Song, Na Lei, Ling Zeng, Xiuyan Li, Cen Jiang, Quansheng Feng, Yue Su, Jibin Liu, Jie Mu
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Observational studies have shown that anti-tumor necrosis factor (TNF) therapy may be beneficial for patients with coronavirus disease 2019 (COVID-19). Nevertheless, because of the methodological restrictions of traditional observational
Externí odkaz:
https://doaj.org/article/1a6472f0b0894304b6998f496cf3c1d3
Autor:
Hua Ye, Beibei He, Yujie Zhang, Ziwei Yu, Yifan Feng, Chuanbiao Wen, Chongcheng Xi, Quansheng Feng
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: In recent years, the incidence and mortality rates of chronic obstructive pulmonary disease (COPD) have increased significantly. Erchen Decoction combined with Xiebai Powder (ECXB) formula is mainly used to treat lung diseases in traditio
Externí odkaz:
https://doaj.org/article/ed1e9609d9334575ae4034c04fa1dc9f
Autor:
Yiyuan Feng, Sha Zhu, Tengwen Liu, Guoguo Zhi, Bingjie Shao, Jibin Liu, Baixue Li, Cen Jiang, Quansheng Feng, Peijie Wu, Dong Wang
Publikováno v:
Pharmaceuticals, Vol 16, Iss 8, p 1114 (2023)
RNA-binding proteins (RBPs), being pivotal elements in both physiological and pathological processes, possess the ability to directly impact RNA, thereby exerting a profound influence on cellular life. Furthermore, the dysregulation of RBPs not only
Externí odkaz:
https://doaj.org/article/25f3926db6b74f178375c4574cc8d8c7
Publikováno v:
PeerJ, Vol 10, p e13737 (2022)
Background Taraxacum mongolicum (TM) is a widely used herb. Studies have reported that TM exhibits growth-inhibitory and apoptosis-inducing on multiple tumors, including hepatocellular carcinoma (HCC). The active ingredients, targets, and molecular m
Externí odkaz:
https://doaj.org/article/04d4041c7fda4723b1f8d8253e206063
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Liver fibrosis is a leading contributor to chronic liver diseases such as cirrhosis and liver cancer, which pose a serious health threat worldwide, and there are no effective drugs to treat it. Qijia Rougan decoction was modified from Sanjiasan, a tr
Externí odkaz:
https://doaj.org/article/f6b3cc1d702d4f3da7030b0a8b29753d